Literature DB >> 2626023

Prostate androgen receptor: immunohistological localization and mRNA characterization.

C Chang1, G Chodak, E Sarac, H Takeda, S Liao.   

Abstract

Four androgen receptor (AR) specific monoclonal antibodies were used for the immunohistochemical localization of AR in the human prostate tissue. The prostate tissue consisted of alveoli embedded in fibromuscular stroma and lined with a single layer of columnar secretory epithelial cells. The immunoreactive ARs were found predominantly in the nuclei of epithelial cell, suggesting ARs, like estrogen receptors and progesterone receptors, are mainly nuclear proteins. Northern blot hybridization showed that AR mRNA is about 9 kilobases (kb) and relative abundant in the androgen-sensitive organs, such as ventral prostate, dorsolateral prostate and seminal vesicle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626023     DOI: 10.1016/0022-4731(89)90099-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

1.  Steroid receptor profile and receptor stability in subfractions of human prostatic tissues. Critical aspects on microassays.

Authors:  J Brolin; L Andersson; P Ekman
Journal:  Urol Res       Date:  1991

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

3.  Androgenic/estrogenic balance in the male rat cerebral circulation: metabolic enzymes and sex steroid receptors.

Authors:  Rayna J Gonzales; Saema Ansar; Sue P Duckles; Diana N Krause
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-04       Impact factor: 6.200

Review 4.  A role for the androgen-receptor in clinically localized and advanced prostate cancer.

Authors:  James L Mohler
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.